Mayo Clinic - Arizona
Mayo Clinic - Arizona
Phoenix, Arizona, United States9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Diagnosing Epilepsy To EffeCT Change | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Not applicable | 2026-10-09 | NCT07110337 | |
| Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors | Solid Tumors | Recruiting | Phase 1 | 2026-09-25 | NCT06963281 | |
| Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up | brain disorder, central nervous system disorder, epilepsy, nervous system disorder | Recruiting | Not stated | 2026-09-15 | NCT07110454 | |
| Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, cardio-renal syndrome, cardiovascular disorder, congestive heart failure, diastolic heart failure, heart disorder, heart failure, kidney disorder, kidney failure, systolic heart failure, urinary system disorder | Recruiting | Not applicable | 2026-08-25 | NCT05677100 | |
| A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-08-06 | NCT07284758 | |
| Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 2 | 2026-06-16 | NCT06106308 | |
| Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-06-12 | NCT05563220 | |
| Avapritinib With Decitabine in Patients With SM-AHN | Systemic Mastocytosis With an Associated Hematologic Neoplasm | Recruiting | Phase 1 | 2026-04-01 | NCT06327685 | |
| A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 3 | 2026-02-27 | NCT06346067 |